oral semaglutide tabletsParkinson’s DiseaseUniversity of Osaka HospitalPDPharmaceuticals and Medical Devices Agency of Japan
…l be randomly assigned in a 1:1:1 ratio to one of three groups: oral semaglutide tablets (7 mg or 14 mg) or placebo. The study drugs will be administere…